Varex Imaging (VREX) Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Varex Imaging in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" VREX shares.
View VREX analyst ratings or view top-rated stocks.

2 brokers have issued 12 month price objectives for Varex Imaging's shares. Their VREX share price forecasts range from $24.00 to $42.00. On average, they anticipate the company's share price to reach $33.00 in the next twelve months. This suggests a possible upside of 77.4% from the stock's current price.
View analysts price targets for VREX or view top-rated stocks among Wall Street analysts.

Varex Imaging's stock was trading at $20.30 at the beginning of 2023. Since then, VREX shares have decreased by 8.4% and is now trading at $18.60.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 21st 2023.
View our VREX earnings forecast.

Varex Imaging Co. (NASDAQ:VREX) released its quarterly earnings results on Tuesday, August, 1st. The company reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.04. The firm had revenue of $232.20 million for the quarter, compared to analyst estimates of $228.57 million. Varex Imaging had a net margin of 3.28% and a trailing twelve-month return on equity of 8.24%. The company's revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.20 earnings per share.

ETFs with the largest weight of Varex Imaging (NASDAQ:VREX) stock in their portfolio include SPDR Kensho Future Security ETF (FITE) and Invesco S&P SmallCap Health Care ETF (PSCH).iShares U.S. Medical Devices ETF (IHI).

Varex Imaging issued an update on its fourth quarter 2023 earnings guidance on Tuesday, August, 1st. The company provided EPS guidance of $0.20-$0.40 for the period, compared to the consensus earnings per share estimate of $0.38. The company issued revenue guidance of $220.00 million-$240.00 million, compared to the consensus revenue estimate of $235.77 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Varex Imaging investors own include Gilead Sciences (GILD), Pfizer (PFE), Varian Medical Systems (VAR), Verizon Communications (VZ), NVIDIA (NVDA), AT&T (T), AbbVie (ABBV), Bausch Health Companies (BHC), Bank of America (BAC) and International Business Machines (IBM).

Varex Imaging trades on the NASDAQ under the ticker symbol "VREX."

Shares of VREX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of VREX stock can currently be purchased for approximately $18.60.

Varex Imaging (NASDAQ:VREX) has a market capitalization of $751.44 million and generates $859.40 million in revenue each year. The company earns $30.30 million in net income (profit) each year or $0.71 on an earnings per share basis.

The company employs 2,300 workers across the globe.

Varex Imaging's mailing address is 1678 SOUTH PIONEER ROAD, SALT LAKE CITY UT, 84104. The official website for the company is www.vareximaging.com. The company can be reached via phone at (801) 972-5000 or via email at howard.goldman@vareximaging.com.